Cargando…
Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
Leishmaniasis is a neglected tropical disease affecting more than 12 million people worldwide, which in its visceral clinical form (VL) is characterised by the accumulation of parasites in the liver and spleen, and can lead to death if not treated. Available treatments are not well tolerated due to...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680852/ https://www.ncbi.nlm.nih.gov/pubmed/31330776 http://dx.doi.org/10.3390/pharmaceutics11070353 |